Skip to main content
Clinical Trials/CTRI/2019/11/022129
CTRI/2019/11/022129Not yet recruitingPhase 4

A Randomized Controlled Study for Evaluation of the Efficacy of Intraperitoneal Instillation of Ropivacaine with Dexmedetomidine Versus Ropivacaine with Ketamine for Post Operative Pain Relief Following Laparoscopic Cholecystectomy

CMS and GTB Hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients of either gender giving consent for the study and aged 20-55 years belonging to ASA grade I or II scheduled for elective laparoscopic cholecystectomy under general anaesthesia.

Exclusion Criteria

  • 1.Patients with cardiovascular, pulmonary, psychological or neurological diseases
  • 2.Patients who are known to be epileptic
  • 3.Patients who have an increase in intracranial tension
  • 4.Patients with known allergies to the study drugs
  • 5.Patients with abnormalities like heart block, left bundle branch block
  • 6.Patients in whom the procedure will be converted to open cholecystectomy
  • 7.Obese patients (BMI more than or equal to 30)
  • 8.Patients in whom subhepatic drain is inserted after the removal of gall bladder.

Investigators

Sponsor
CMS and GTB Hospital

Similar Trials